Viemed Healthcare (NASDAQ:VMD) Now Covered by Barrington Research

Analysts at Barrington Research initiated coverage on shares of Viemed Healthcare (NASDAQ:VMD) in a research report issued to clients and investors on Monday. The firm set an “outperform” rating and a $14.00 price target on the stock. Barrington Research’s price target points to a potential upside of 58.19% from the company’s previous close.

A number of other equities analysts have also recently issued reports on the company. Freedom Capital cut Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 5th. Weiss Ratings cut shares of Viemed Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, August 17th. Finally, Wall Street Zen downgraded shares of Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 15th. One research analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $14.00.

Viemed Healthcare Stock Performance

Shares of VMD opened at $8.85 on Monday. The firm has a 50-day moving average price of $10.98 and a 200 day moving average price of $9.87. The company has a quick ratio of 1.02, a current ratio of 1.13 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of $337.10 million, a PE ratio of 24.58 and a beta of 1.10. Viemed Healthcare has a 52-week low of $6.05 and a 52-week high of $12.61.

Viemed Healthcare (NASDAQ:VMD) last posted its quarterly earnings data on Monday, August 3rd. The company reported $0.07 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.05). Viemed Healthcare had a net margin of 4.81% and a return on equity of 10.16%. The company had revenue of $78.10 million for the quarter, compared to analyst estimates of $78.00 million. On average, sell-side analysts anticipate that Viemed Healthcare will post 0.42 earnings per share for the current fiscal year.

Insider Transactions at Viemed Healthcare

In other news, Director Timothy Smokoff sold 20,000 shares of Viemed Healthcare stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total value of $230,000.00. Following the transaction, the director owned 75,518 shares of the company’s stock, valued at $868,457. This trade represents a 20.94% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider William Frazier sold 10,000 shares of Viemed Healthcare stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $11.72, for a total transaction of $117,200.00. Following the completion of the transaction, the insider owned 73,214 shares in the company, valued at $858,068.08. This trade represents a 12.02% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 20.60% of the company’s stock.

Institutional Trading of Viemed Healthcare

Several hedge funds have recently added to or reduced their stakes in VMD. State of Alaska Department of Revenue bought a new stake in shares of Viemed Healthcare in the fourth quarter valued at approximately $25,000. Kemnay Advisory Services Inc. acquired a new stake in Viemed Healthcare in the 4th quarter worth $46,000. Quarry LP acquired a new stake in Viemed Healthcare in the 3rd quarter worth $48,000. California State Teachers Retirement System increased its holdings in shares of Viemed Healthcare by 189.0% during the 2nd quarter. California State Teachers Retirement System now owns 5,347 shares of the company’s stock worth $61,000 after purchasing an additional 3,497 shares during the period. Finally, Globeflex Capital L P bought a new position in shares of Viemed Healthcare during the 2nd quarter worth about $86,000. Institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.